nomilin has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuttan, G; Pratheeshkumar, P | 1 |
Ahmad, H; Miller, EG; Patil, BS; Tang, L; Tian, Q | 1 |
2 other study(ies) available for nomilin and Benign Neoplasms
Article | Year |
---|---|
Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.
Topics: Animals; Antineoplastic Agents; Aorta; Benzoxepins; Capillaries; Cell Movement; Cell Proliferation; Collagenases; Cytokines; Down-Regulation; Enzyme Activation; Gelatin; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Limonins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neoplasms; Neovascularization, Pathologic; Nitric Oxide; Rats; Vascular Endothelial Growth Factor A | 2011 |
Differential inhibition of human cancer cell proliferation by citrus limonoids.
Topics: Apoptosis; Benzopyrans; Benzoxepins; Breast Neoplasms; Cell Division; Citrus; DNA, Neoplasm; Female; Flow Cytometry; Glucosides; Humans; Leukemia; Limonins; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Plant Extracts; Stomach Neoplasms; Triterpenes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |